NEUROPACE INC's ticker is NPCE and the CUSIP is 641288105. A total of 29 filers reported holding NEUROPACE INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,456,000 | -42.1% | 388,368 | -23.5% | 0.02% | -41.7% |
Q2 2022 | $2,514,000 | -39.7% | 507,930 | 0.0% | 0.04% | -25.0% |
Q1 2022 | $4,170,000 | -18.6% | 507,930 | 0.0% | 0.05% | -9.4% |
Q4 2021 | $5,120,000 | -36.4% | 507,930 | 0.0% | 0.05% | -35.4% |
Q3 2021 | $8,051,000 | -33.4% | 507,930 | 0.0% | 0.08% | -30.5% |
Q2 2021 | $12,084,000 | – | 507,930 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KCK LTD. | 5,621,111 | $54,693,410 | 77.70% |
Soleus Capital Management, L.P. | 2,466,205 | $23,996,175 | 2.21% |
Kent Lake Capital LLC | 574,417 | $5,589,077 | 2.15% |
Nantahala Capital Management | 1,219,915 | $11,869,773 | 1.01% |
Orbimed Advisors | 4,012,281 | $39,039,494 | 0.83% |
EAM Investors, LLC | 141,616 | $1,377,924 | 0.27% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 60,048 | $584,267 | 0.01% |
Financial Advocates Investment Management | 10,000 | $97,300 | 0.01% |
MORGAN STANLEY | 2,399,716 | $23,349,237 | 0.00% |
FMR LLC | 706,245 | $6,871,765 | 0.00% |